Fragasso Financial Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
6,432
+35
+0.5% +$7.25K 0.07% 128
2026
Q1
$1.44M Buy
6,397
+428
+7% +$107K 0.09% 104
2025
Q4
$1.44M Sell
5,969
-40
-0.7% -$10.2K 0.09% 103
2025
Q3
$1.67M Sell
6,009
-1,087
-15% -$297K 0.1% 95
2025
Q2
$1.83M Sell
7,096
-664
-9% -$158K 0.12% 84
2025
Q1
$1.74M Sell
7,760
-662
-8% -$155K 0.13% 82
2024
Q4
$1.93M Sell
8,422
-500
-6% -$120K 0.15% 82
2024
Q3
$2.18M Buy
8,922
+1,712
+24% +$383K 0.17% 78
2024
Q2
$1.38M Buy
+7,210
New +$1.46M 0.11% 100

Other funds holding RMD

Fragasso Financial Advisors's RMD Position: Q2 2026 in Review

Fragasso Financial Advisors increased its ResMed (RMD) stake by 0.55% in Q2 2026, buying an estimated $7.25K and bringing the position to 6,432 shares worth $1.25M. The position accounts for 0.07% of the portfolio, ranked #128.

Fragasso Financial Advisors first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.18M in Q3 2024. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Fragasso Financial Advisors held 6,432 shares of ResMed worth $1.25M as of Q2 2026.
  • Fragasso Financial Advisors bought 35 ResMed shares in Q2 2026, an estimated $7.25K.
  • ResMed made up 0.07% of Fragasso Financial Advisors's portfolio in Q2 2026, its #128 holding.
  • Fragasso Financial Advisors first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • Fragasso Financial Advisors's ResMed position peaked at $2.18M in Q3 2024.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.